Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05993260
  4. Details
NCT05993260 Clinical Trial

Using Text Messages to Boost COVID-19 Vaccine Booking Rate

COVID-19 Clinical Trial

Official title:
Using Text Messages to Boost COVID-19 Vaccination Appointment Booking and Vaccination Rates: A Randomised Controlled Field Trial.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05993260
Other study ID # 2021035
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 26, 2021
Est. completion date May 10, 2021

Study information
Verified date August 2023
Source The Behavioural Insights Team
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a nationwide randomised controlled trial (RCT) to test the impact of behavioural science-informed text messages notifying patients of their eligibility for the COVID-19 vaccine on vaccination rates.

Recruitment information / eligibility
Status Completed
Enrollment 1825937
Est. completion date May 10, 2021
Est. primary completion date April 29, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 44 Years
Eligibility Inclusion Criteria: - (i) satisfying the age criteria as defined above; - (ii) recorded in the National Immunisation Management System (NIMS); - (iii) with a valid mobile phone number; - (iv) who had not already received or been invited for the COVID-19 vaccine via NIMS at the time of the study. Exclusion Criteria: - Participants with invalid phone numbers

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Behavioural science-informed text messages
Behaviourally-informed content in vaccination eligibility reminder text messages
• Control
Control vaccination eligibility reminder text message

Locations
Country Name City State
United Kingdom NHS England London

Sponsors (4)
Lead Sponsor Collaborator
The Behavioural Insights Team Department of Health and Social Care, NHS England and NHS Improvement, Public Health England

Country where clinical trial is conducted

United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Booking rate within 72 hours The proportion of first dose vaccination appointments booked through the NHS National Booking System within 72 hours (inclusive) of the text message being sent 72 hours
Secondary Vaccination rate within 14 days The proportion of first dose vaccinations received within 14 days (inclusive) of the text message being sent 14 days
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure